Anne Stern

Title: **Anne Stern: Innovator in Protein Expression Technologies**

Introduction

Anne Stern, a prominent inventor based in Penzberg, Germany, has made remarkable contributions to the field of biotechnology with a total of 26 patents to her name. Her extensive work focuses on the innovative processes for protein expression, particularly in mammalian cell lines.

Latest Patents

One of Anne Stern's latest patents is titled "Protein expression from multiple nucleic acids." This invention details a sophisticated method for the recombinant production of a secreted heterologous immunoglobulin in CHO (Chinese Hamster Ovary) cells. The process encompasses several key steps: first, utilizing CHO cells that are adapted to suspension culture and serum-free conditions. Next, a vector is provided that contains various nucleic acids, which enable the cells to express both the heavy and light chains of the immunoglobulin. The transfection and selection processes are rigorously outlined, ensuring the cultivation of CHO cells capable of expressing the desired immunoglobulin efficiently.

Career Highlights

Throughout her career, Anne has been associated with notable companies in the biotechnology sector, including Roche Diagnostics GmbH and Boehringer Mannheim GmbH. Her roles at these organizations have allowed her to develop and refine her innovative methodologies, leading to significant advancements in protein production technologies.

Collaborations

Anne has collaborated with esteemed coworkers, including Erhard Kopetzki and Konrad Honold. Together, they have contributed to the advancement of biotechnological processes, bringing forth innovative solutions that benefit the industry as a whole.

Conclusion

As a dedicated inventor and innovator, Anne Stern continues to push the boundaries of protein expression technologies, securing her place as a leading figure in the biotech industry. Her patents not only underscore her expertise but also highlight the potential for future advancements in the field.